Girao Tiago
Girao Tiago, CFO, reported an open-market or private sale at Immunovant, Inc. involving 6606.000000 shares for an estimated $188271.00. Reported holdings after the transaction were 234192.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Oct 28, 2026
- Filing date
- Oct 30, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 240,798 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
IMVT price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001764013-26-000117 Common Stock
- Transaction date
- Oct 28, 2026 Filed Oct 30, 2026, 08:37 PM · 2d delay
- Shares
- 6,606 sh $28.50 per share
- Estimated value
- -$188k Computed from shares × price
- Holdings after
- 234,192 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+10 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Financial Officer
- F1
On May 1, 2025, the holder was granted 208,388 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on May 5, 2025, of which 13,024 of these RSUs vested on October 21, 2026.
The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated b…
- F2
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.34 - $28.50 per share, inclusive. The Reporting Person undertakes to provide…
0 other transactions
0 recent txs